Luye Pharma Group Ltd Stock Singapore S.E.
Equities
LUYE
BMG5722Z1014
Pharmaceuticals
Sales 2023 | 6.14B 848M 1.15B | Sales 2024 * | 7B 966M 1.31B | Capitalization | 9.4B 1.3B 1.76B |
---|---|---|---|---|---|
Net income 2023 | 533M 73.55M 100M | Net income 2024 * | 669M 92.32M 126M | EV / Sales 2023 | 2.08 x |
Net Debt 2023 * | 3.67B 506M 688M | Net Debt 2024 * | 2.95B 407M 553M | EV / Sales 2024 * | 1.76 x |
P/E ratio 2023 |
23.7
x | P/E ratio 2024 * |
15.6
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 54.94% |
Managers | Title | Age | Since |
---|---|---|---|
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 03-07-01 |
Rong Bing Yang
PSD | President | 58 | 94-06-07 |
Yun Li Xue
PRN | Corporate Officer/Principal | 60 | 94-06-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hui Xian Yuan
BRD | Director/Board Member | 65 | 94-06-07 |
Rong Bing Yang
PSD | President | 58 | 94-06-07 |
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 03-07-01 |
1st Jan change | Capi. | |
---|---|---|
+25.14% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.47% | 233B | |
+5.67% | 201B | |
-10.10% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |